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Abstract.  Oligonucleotide-directed mutagenesis was 
used to construct chimeric cDNAs that encode the 
extracellular and transmembrane domains of the ve- 
sicular stomatitis virus glycoprotein (G) linked to the 
cytoplasmic domain of either the immunoglobulin u 
membrane heavy chain, the hemagglutinin glycopro- 
tein of influenza virus, or the small glycoprotein (023) 
of infectious bronchitis virus. Biochemical analyses 
and immunofluorescence microscopy demonstrated 
that these hybrid genes were correctly expressed in 
eukaryotic cells and that the hybrid proteins were 
transported to the plasma membrane. The rate of 
transport to the Golgi complex of G protein with an 
immunoglobulin # membrane cytoplasmic domain 
was approximately sixfold slower than G protein with 
its normal cytoplasmic domain. However, this rate 
was virtually identical to the rate of transport of ~m 
heavy chain molecules measured in the B cell line 
WEHI 231.  The rate of transport of G protein with a 
hemagglutinin cytoplasmic domain was threefold 
slower than wild type G protein and G protein with a 
p23 cytoplasmic domain, which were transported at 
similar rates. The combined results underscore the im- 
portance of the amino acid sequence in the cyto- 
plasmic domain for efficient transport of G protein to 
the cell surface. Also, normal cytoplasmic domains 
from other transmembrane glycoproteins can substi- 
tute for the G protein cytoplasmic domain in trans- 
port of G protein to the plasma membrane. The 
method of constructing precise hybrid proteins de- 
scribed here will be useful in defining functions of 
specific domains of viral and cellular integral mem- 
brane proteins. 
I 
NTEGRAL membrane proteins and secretory proteins are 
synthesized on membrane-bound  ribosomes of the en- 
doplasmic reticulum (ER)  I. Signal peptides, required to 
initiate transfer of nascent polypeptides across the ER during 
synthesis, have been identified for most eukaryotic secretory 
and integral membrane proteins thus far examined (7,  51). 
Addition of high mannose core oligosaccharides occurs on 
the cisternal surface of the rough ER during translocation of 
the nascent chain (49). Hydrophobic regions of 20-30 amino 
acids serve to anchor glycoproteins in the membrane. Secre- 
tory proteins lack these transmembrane hydrophobic regions 
and are completely translocated  across the ER membrane. 
Also, complete translocation of the extracytoplasmic domain 
1. Abbreviations used in this paper, t~m, immunoglobulin ~ membrane heavy 
chain; DME, Dulbecco's modified Eagle's medium; endo H, endoglycosidase 
H: ER, endoplasmic retieulum; FCS, fetal  calf serum; G*, G  protein with a 
shortened cytoplasmic domain; Gu,  G  protein  with an  immunoglobulin 
membrane heavy chain cytoplasmic domain; HA, hemagglutinin; IBV, infec- 
tious  bronchitis virus; u=,  immunoglobulin t~  membrane heavy chain; ~, 
immunoglobulin  g secreted heavy chain; SV40, simian virus 40; VSV, vesicular 
stomatitis virus. 
of  proteins occurs when the transmembrane and cytoplasmic 
domains are artificially  deleted from cDNAs encoding integral 
membrane proteins (19, 48, 57). From their site of synthesis 
in the rough ER, integral membrane and secretory proteins 
are transferred to their site of  function, which  can include the 
ER, Golgi complex, lysosomes, or plasma membrane. The 
mechanisms that direct proteins to these specific destinations 
in the  cell are  not well understood,  with the  exception of 
mannose 6-phosphate which targets some enzymes to lyso- 
somes (10, 13). 
The pathway of biogenesis of the vesicular stomatitis virus 
(VSV) glycoprotein (G) has been well characterized and serves 
as a model for many viral and cellular integral membrane 
proteins targeted to the plasma membrane. In VSV-infected 
cells, G protein  is transported  from its site of synthesis in 
rough ER (24, 38) and nuclear membranes (41) to a site in 
the Golgi complex where its oligosaccharides are modified 
(58). G protein is finally transported to the plasma membrane 
where it is incorporated into budding virions (26). The same 
pathway of  G protein biogenesis  is observed in the absence of 
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is expressed under control of the simian virus 40 (SV40)  late 
promotor in transfected cells (48). 
An earlier study on VSV G  protein addressed the role of 
the  cytoplasmic  domain  in  this  transport  process.  When 
cDNA clones encoding  G  proteins in  which  the  carboxyl- 
terminal half of the normal cytoplasmic domain was replaced 
with  3-23  extraneous  amino  acids  encoded  by  SV40  are 
expressed in transfected cells, G protein is transported to the 
cell surface at a much slower rate than the wild type G protein 
(as suggested by rate  of acquisition  of sugars in  the  Golgi 
complex that are resistant to removal by endoglycosidase H 
[endo H]). When the entire normal 29 amino acid cytoplasmic 
domain is deleted from G  protein and replaced with 3 or 12 
vector-encoded amino acids, G protein accumulates in rough 
ER and nuclear membranes and is not transported to the cell 
surface (47).  A different approach to examining the role of 
the cytoplasmic domain in transport of G protein to the cell 
surface yielded similar results.  In VSV-infected cells, microin- 
jection of antibodies directed against the 11 carboxyl-terminal 
amino acids in the cytoplasmic domain of G protein has little 
effect on the exocytotic transport of G protein, but microin- 
jection of antibodies directed against the 22 carboxyl-terminal 
amino acids in the cytoplasmic domain completely abolishes 
G  protein  transport  to  the  surface (4).  These  studies,  and 
similar studies examining expression of cDNA clones encod- 
ing the Rous sarcoma virus or influenza virus envelope gly- 
coproteins with altered cytoplasmic domains, show that the 
structure of the cytoplasmic domain is important to a normal 
rate ofglycoprotein transport to the cell surface (15, 62). Such 
studies  suggested  that  the  cytoplasmic domains  of at  least 
some proteins might constitute signals that facilitate transport 
to the cell surface. Deletions have also been constructed in 
regions of cDNA clones which  specify the  cytoplasmic do- 
mains of the Semliki Forest virus E2 glycoprotein (18)  or a 
murine  major histocompatibility antigen  (H-2L  d)  (39,  65). 
These mutant glycoproteins are expressed on the cell surface. 
However, portions of the normal cytoplasmic domains were 
retained  in  the  constructions (3/31,  7/31,  or  11/31  amino 
acids) and rates of transport through the cell were not mea- 
sured. 
At least two types of cellular transmembrane surface gly- 
coproteins have very short cytoplasmic domains consisting of 
three amino acid  residues,  immunoglobulin ~  and 5 mem- 
brane heavy chains (#m, 5m) (11,  25).  From previous studies 
it was determined that biosynthesis and maturation of.//m or 
5m occurs via a pathway similar to the VSV G  protein: from 
the  rough  ER  through  the  Golgi  complex  to  the  plasma 
membrane (53,  60).  Thus, if the cytoplasmic domain is im- 
portant for directed transport of these proteins, three amino 
acids must be sufficient. 
In  this  study,  we  generated  chimeric  cDNAs  in  which 
nucleotides encoding the cytoplasmic domains of other inte- 
gral  membrane proteins were substituted  for nucleotides of 
the G gene encoding its cytoplasmic domain. Specifically,  we 
were able to construct G genes encoding the extracellular and 
transmembrane domains of G  protein and the cytoplasmic 
domain of Urn, the hemagglutinin (HA) glycoprotein of influ- 
enza virus, or the small glycoprotein (p23) of infectious bron- 
chitis  virus (IBV). When  these genes were expressed under 
control  of the  SV40  late promotor in  eukaryotic cells,  the 
hybrid glycoproteins were transported to the plasma mem- 
brane. Each hybrid protein was transported from the rough 
ER through the Golgi complex at a different rate, and in one 
case, that of G protein with the Urn cytoplasmic domain, this 
rate was the same as the normal rate of transport of the intact 
parent um glycoprotein. 
Materials and Methods 
Oligonucleotide-directed Mutagenesis 
Synthetic oligonucleotides used here (34mer, 25met, and 60mer) were synthe- 
sized on a  DNA synthesizer (Applied Biosystems, Inc.,  Foster  City, CA or 
model 1450A, Sys-Tec, Inc., New Brighton, MN) using phosphoramidite chem- 
istry.  Deblocked  oligonueleotides  were purified  by  electrophoresis  on  12% 
polyacrylamide  gels. Each  oligonucleotide  primer was annealed  to purified 
DNA from an rap8 bacteriophage that contains the negative strand of the G 
gene (mp8-G4). Extension of primers on the phage template  was carried out 
using the Klenow fragment  of DNA polymerase  I as described (46). Single- 
stranded template remaining after the extension was nicked by incubation with 
a low concentration  of S1  nuclcase before transformation  of Escherichia coil 
strain  JMI03  (33). 15-25% of plaques  screened  hybridized  (21) with  the 
respective 5'-[32p]-labeled oligonucleotide.  Phage replicative-form  DNA  was 
prepared from colonies that hybridized with the oligonucleotide and the frag- 
ments containing each of the mutant G genes were excised and ligated into the 
Xhol site of  the SV40-based expression vector pJCl 19 (54). Correct orientation 
of  the insert was determined by digestion with restriction enzymes. The nucleo- 
tide sequence at the site of the mutation was confirmed using the technique of 
Maxam and Gilbert (35). Initial attempts to use a 28mer to introduce the same 
mutation  in  the  G  gene  generated  by  the  34mer  were unsuccessful.  This 
oligonucleotide, which contained  only eight complementary  terminal  nucleo- 
tides, appeared to hybridize to, but was not extended on, the mp8-G4 phage 
template. 
Construction of  pG23 
cDNA-encoding IBV p23 was cloned from viral genomic RNA (55), and the 
complete  nucleotide  sequence  of a  subclone  (p57-6) containing  the  coding 
region was determined (J. Rose, unpublished results). The sequence predicts a 
polypeptide of 225 amino acids, and differs in only a few nucleotides from a 
sequence  recently  published  for the  p23  gene of IBV (9). A  780  base-pair 
fragment containing the complete coding sequence of  p23 was subcloned, using 
Xhol linkers, into the single XhoI site of the expression vector pJC119 (54). 
An  internal  BamH1 site at nucleotide  338  (equivalent  to nucleotide  453  in 
reference 9) was utilized to generate a fragment containing  the  3' half of the 
coding sequence.  This  fragment  includes  the  entire  sequence  encoding  the 
putative  cytoplasmic domain of p23 (9, 50). This fragment  was ligated to a 
BamHl fragment containing the sequence encoding the extracellular and trans- 
membrane domains of G protein,  as well as the four amino-terminal  amino 
acids derived from the G cytoplasmic domain, and reinserted into pJC 119. The 
G-encoding fragment was obtained  from a mutant generated by oligonucleo- 
tide-directed  mutagenesis of the  G gene, with a single nucleotide  change at 
position 1483 (46) to produce a BamHl site (plasmid pTMB). This recombinant 
results in the in-frame fusion of the coding sequences of G protein  and p23, 
and was expected to encode a hybrid protein of 612 amino acids: the amino- 
terminal 485 amino acids of G protein, and the carboxyl-terminal  127 amino 
acids of p23. 
Cell Lines and Viruses 
COS-1 cells originally established by Gluzman (20) were maintained  in Dul- 
becco-Vogt's modified  Eagle's medium (DME)  supplemented  with 5%  fetal 
calf serum  (FCS). A subcloned  line of WEHI 231  cells (WEHI 231.2.TG.3) 
(42) was obtained from William C. Raschke (La JoUa Cancer Research Foun- 
dation, La Jolla, CA). These cells were maintained in DME supplemented with 
10% heat-inactivated FCS and 50 ~M 2-mercaptoethanol. 
Stocks of wild type  VSV, San Juan strain  of the  Indiana  serotype, were 
prepared by infection of baby hamster kidney cells with virus at a multiplicity 
of 0.01 plaque-forming units/cell for 16 h. Clarified culture supernatants  were 
used as virus stocks for experiments. 
Antibodies and lmmunofluorescent Staining 
Indirect immunofluorescence microscopy oftransfected COS- 1  cells was carried 
out essentially as previously described (48). Paraformaldehyde-fixed cells were 
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by rhodamine-  or Texas Red-conjugated goat anti-rabbit  IgG (1:200) (Cappel 
Laboratories, Cochranville, PA, or Jackson Immunolabs, Avondale, PA). The 
affinity-purified secondary antibodies obtained from Jackson Immunolabs  used 
in some of these experiments  exhibited  lower background  fluorescence than 
the non-affinity-purified  conjugated  antibodies  used in previous studies (47). 
Thus, our ability to detect  low levels of cell-surface  fluorescence was signifi- 
cantly greater than previously described. After permeabilization with detergent, 
cells were  incubated  in  hyperimmune mouse serum directed  against  VSV 
(1:200), then fluorescein-conjugated affinity-purified rabbit or goat anti-mouse 
IgG (1:20) (Cappel Laboratories). The anti-VSV serum prepared in mice was 
obtained  from Douglas  S.  Lyles (Wake  Forest  University  Medical  Center, 
Winston-Salem, NC). 
Transfection and Labeling of COS-1  Cells 
Transfection  of COS-I  cells with  plasmid  DNA  precipitated  with  DEAE- 
dextran was performed as described (1). Approximately 40 h after transfection, 
cells were depleted  of methionine  by incubation  with methionine-free  DME 
for 15 min. Cells were pulse-labeled for 15 min with [35S]methionine ( 100 uCi/ 
ml, >600 Ci/mmol) in methionine-free  medium containing  2% dialyzed FCS, 
then  chased  by  incubation  in  medium containing  5%  FCS  and  unlabeled 
methionine  (2 mM) for varying lengths of time.  Proteins  from cells at each 
time point were solubilized in detergent  solution  (10 mM Tris, pH 7.4, 1% 
Nonidet P-40, 0.4% deoxycholate, 66 mM EDTA, 1 mM phenylmethylsulfonyl 
fluoride, and 100 U kallikrein inhibitor/ml) and nuclei removed by centrifuga- 
tion at 15,000 g for 15 rain. Immunoprecipitation  of G protein with anti-VSV 
serum and  treatment  of immunoprecipitated  proteins  with  endo  H  (Miles 
Scientific Div.,  Miles Laboratories  Inc.,  Naperville, IL) has been  previously 
described (47). The protein  composition  of each  sample  was determined  by 
SDS-polyacrylamide gel electrophoresis (27) and fluorography (8) using preex- 
posed Kodak XAR film (29). 
Biosynthetic Labeling of B Lymphoblastoid Cells 
WEH1231 cells were washed with Dulbecco's phosphate-buffered saline (DPBS) 
and suspended in methionine-free DME for 15 rain. Cells (7.5 ×  106/ml) were 
pulse-labeled for 10 min with [35S]methionine ( 100 uCi/ml) in methionine-free 
medium containing  2%  dialyzed  FCS and  50  #M  2-mercaptoethanol,  then 
chased by incubation  in maintenance  medium containing an additional 2 mM 
unlabeled methionine  for varying lengths of time. Cells from each time point 
were washed with DPBS and proteins were solubilized with detergent solution. 
Proteins  present  on the  plasma  membrane were labeled with  [12~I] using a 
lactoperoxidase-catalyzed technique (33). Nuclei and other cellular debris were 
removed by centrifugation  at  100,000 g for 1 h. Supernatants  from an equiva- 
lent  of 1.2  x  10  6 cells were precleared with  100 ~1 of a  10%  suspension of 
Staphylococcus aureus cells. The supernatant was adjusted  to 0.5% SDS (52) 
and subjected to immunoprecipitation  with goat anti-mouse IgM (heavy chain- 
specific, Miles Scientific Div.) or rabbit anti-mouse ~ light chain (obtained from 
Rick Riley, Scripps Clinic and Research Foundation,  La Jolla, CA). The extracts 
were incubated  with sufficient antiserum  for complete precipitation  for 2 h at 
4"C, followed by  incubation  with  protein  A-Sepharose 4B  for  1 h  at  4"C. 
lmmunoprecipitates  were  washed  six times  with  radioimmunoprecipitation 
assay (RIPA) buffer (10 mM Tris [pH 7.4], 0.15 M NaCI,  1% Nonidet  P-40, 
1%  sodium deoxycholate,  0.1% SDS,  I  mM phenylmethylsulfanyl  fluoride, 
and  100  U  kallikrein  inhibitor/ml) (32). lmmunoprecipitated  proteins  were 
eluted from Sepharose beads and their disulfide bonds reduced by incubation 
in  1 M Tris (pH 8.8), 2% SDS, and  10 mM dithiothreitol  for 3 rain at 100*C. 
Proteins alkylated by incubation  in 30 mM iodoacetamide at room temperature 
for I h (5) were precipitated with acetone at -20"C. Precipitates were washed, 
boiled with 2% SDS, then treated with endo H (59). The protein composition 
of each sample was analyzed by electrophoresis on a  12% SDS-polyacrylamide 
gel and fluorography. 
WEHI 231  cells were infected in the presence of 5 ug/ml actinomycin  D 
with  30  plaque-forming  units  of VSV/celI. At  5 h  postinfection,  cells were 
collected and washed with DPBS. Before labeling, infected cells were depleted 
of methionine  by incubation with methionine-free DME for 15 min. Cells were 
pulse-labeled for 5 rain  with [35S]methionine (25 uCi/ml) in methionine-free 
medium containing  2% dialyzed FCS, then chased by incubation  in medium 
containing  excess unlabeled  methionine  (2 mM) for varying lengths of time. 
Proteins  from  cells at  each  time  point  were  solubilized  and  subjected  to 
immunoprecipitation  with anti-VSV serum. As described above for transfected 
cells, immunoprecipitated  proteins were treated with endo H and analyzed by 
SDS-polyacrylamide gel electrophoresis and fluorography. 
Results 
Oligonucleotide-directed Domain Replacement 
We designed a  method to construct hybrid glycoproteins in 
which the cytoplasmic domain of VSV G protein was replaced 
with  the  corresponding domains  from  other proteins.  We 
define cytoplasmic domains of proteins having similar mem- 
brane topology as G protein as that sequence of amino acids 
from the first basic amino acid residue immediately following 
the  transmembrane domain  to  the  carboxyl-terminus.  To 
avoid problems encountered in previous studies (15,  18,  37, 
39, 43, 47, 62, 65) of assessing the contribution of endogenous 
or extraneous amino acids to functional domains of proteins, 
we chose to extend the oligonucleotide-directed mutagenesis 
technique (46) to replace large stretches of nucleotides instead 
of single nucleotides. 
Nucleotides in the G gene that encode the first four amino 
acids in the cytoplasmic domain of G  protein were replaced 
with nucleotides that encode the three amino acid cytoplasmic 
domain of IgM or IgD membrane heavy chains and a termi- 
nation codon. As deduced  from sequences of DNA  clones, 
the cytoplasmic domains Of#m and 6m are identical and consist 
of the amino acids Lys-Val-Lys (11, 25). As illustrated in Fig. 
1A,  an  oligonucleotide  (34mer)  was  hybridized to  circular 
template  DNA  containing the G  gene  sequence  (mp8-G4) 
and the primer was extended.  This  primer encodes the se- 
quence  Lys-Val-Lys  followed by  a  translation  termination 
codon, and is flanked by  11  nucleotides complementary to 
the G gene on each side. After transfection of this DNA into 
E. coli we obtained phage carrying the desired replacement of 
12  nucleotides.  The mutant gene was then subcloned from 
the double-strand replicative-form DNA into the SV40-based 
expression vector pJC119  (54).  The plasmid was designated 
pGu. 
Using  the same technique,  we introduced a  termination 
codon following nucleotides encoding the first  three amino 
acids of the normal cytoplasmic domain of G  protein (Fig. 
1B).  Finally, a  synthetic 60mer was used to replace 29  nu- 
cleotides in the cytoplasmic domain of G  protein with nu- 
cleotides encoding the cytoplasmic domain of an HA glyco- 
protein of influenza virus and a termination codon (Fig.  1 C). 
The  plasmid  DNAs  for expression  in  eukaryotic cells  that 
carry these mutant G genes were designated laG* and pGHA, 
respectively. 
Expression and Transport of G Protein with the Um 
Cytoplasmic Domain 
All mutant genes studied here were inserted into the SV40- 
based vector pJC119  (54) and transfected onto COS-I  cells 
(20).  These cells support extensive replication of the vector, 
therefore a  high  level  of G  protein synthesis is observed in 
cells that  express  the transfected genes (1,  33,  47,  48).  To 
determine if the three amino acid cytoplasmic domain of Um 
was sufficient for transport of G  protein to the cell surface, 
we performed double-label indirect immunofluorescence mi- 
croscopy of COS-1  cells transfected with  the  plasmid  pGtz 
that encodes G protein with the u,, cytoplasmic domain (Gu). 
It  should be  noted that this and  all  other mutant proteins 
were analyzed by SDS-polyacrylamide gel electrophoresis (see 
below) and were found to have the apparent molecular weights 
predicted from the DNA sequence. Fig. 2 shows both surface 
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..........  LeuVtlLeu]LysValLys-COOH 
TCTTGGTTCTcAAAGTTAAATAAcATCTTTGCAT  (Ixirr4r,~ m~ 
....  GATAAGAACCAAGAGGCTCAAccATAGGTAGAAACGTAATTT  ....  (~r~ffi 
B 
G TM Doi'r~n  G*~  Domakl 
..........  LeuValLeu[ArgValGly-COOH 
TCCGAGTTGGTTAACATCTTTGCAT  (pnmm'.  25 mer) 
....  GATAAGAACCAAGAGGCTCAACCATAGGTAGAAACGTAATTT  ....  (templm) 
C 
G TM Domain  HA Cytopiam'~ Domain 
.-:-  ........  Le uVe I Leu~r  gGI '/As n I  I eAr gCysAsn  I  IaCy s I  I e-COOH 
AACATCAGGTGCAACATTTGCATTT. 
TCTTGGTTCTCCGAG QC  AACACACCAAGAAAAGAC  (primer, 60 met) 
....  GATAAGAACCAAGAGGCTCAAp~  .TTCGTGTGGTTCTTTTCTGTCTA  ....  [template) 
"~'ATAGGTAGAAACGTAATTTAA / 
and internal fluorescence labeling patterns of the same cells 
expressing each of the indicated glycoproteins. As expected, 
the wild type G protein is present on the cell surface. Internal 
labeling of G  protein in the nuclear membrane and a GolD- 
like region is detected in some cells expressing the wild type 
G  protein  but  is  frequently  difficult  to  resolve due  to  the 
extensive accumulation  of G  protein  on  the  plasma mem- 
brane (Fig. 2, A and B; 48). In most cells (60-90%) expressing 
G# or G  protein with a shortened cytoplasmic domain (G*), 
immunofluorescent  labeling  of the  plasma  membrane was 
observed (Fig. 2, C-F), however it appeared less intense than 
for the wild type G  protein. The internal labeling pattern of 
transfected cells that expressed G  proteins with cytoplasmic 
domains of three  amino acids included  a  reticular  ER-like 
pattern  including  the  nuclear  envelope  and  a  perinuclear 
Goigi-like  region.  These  results  suggest  that  a  short  cyto- 
plasmic domain derived from a normal cellular glycoprotein 
Um and a shortened cytoplasmic domain from G  protein are 
functional in transport of G protein to the cell surface. 
Cells that express the 1473H 1 glycoprotein in which all the 
normal cytoplasmic domain of G  protein has been removed 
(47)  were  reexamined as  controls  for immunofluorescence 
microscopy experiments.  This  protein  contains  a  putative 
cytoplasmic domain of two to three uncharged amino acids 
(Pro-Ser-Ser) encoded by a synthetic DNA linker. The major- 
ity of cells  that  express  1473H1  were stained essentially as 
previously described in which the  mutant protein appeared 
to be concentrated in a reticular ER-like pattern (Fig. 2 G) but 
not on the cell surface (Fig. 2/10. Although surface expression 
was not  detected  previously (47),  we  found that  when  the 
combination of antibodies was optimized for immunolabeling 
of the cell surface, -20% of the cells showed labeling of the 
Figure  1.  Oligonucleotide-directed  do- 
main  replacement.  The  oligonucleotide 
primers used in this study (34mer, 25mer, 
and 60mer) are shown hybridized to tem- 
plate  DNA from  the  mp8-G4  bacterio- 
phage.  Incorporation  of  the  indicated 
mismatched bases (bold letters) into the 
cDNA-cioning G protein will change co- 
dons in the region of  the G gene encoding 
the  cytoplasmic domain.  Such replace- 
ment of nucleotides results in precise fu- 
sions of the extracellular and transmem- 
brane domain of G protein with the cy- 
toplasmic domains of um (A) or of HA 
glycoprotein of influenza virus (C; e.g., 
strain A/Aichi/2/68;  61). A precise ter- 
mination  within the  G  protein  cyto- 
plasmic domain  coding region was also 
generated (B). 
protein  on  the  plasma  membrane  (Fig.  2,  I-J).  It  is  not 
surprising that in previous studies immunofluorescent label- 
ing of 1473H1  on the cell surface was undetected (47).  In a 
preliminary experiment performed in this study utilizing the 
same  rhodamine-conjugated  second-step  anti-rabbit  serum 
used in the earlier report, results similar to those previously 
described were obtained.  However, in  this  study when  the 
sample size  was significantly increased and  the  experiment 
repeated three to five times utilizing an affinity-purified sec- 
ond-step antibody, our ability to more accurately quantitate 
low levels of cell-surface fluorescence significantly increased. 
It is interesting to note that using the new antibody combi- 
nation, immunolabeling of the plasma membrane was never 
observed for mutant 1473 as reported (47). 
During synthesis of G  protein on  rough ER  and  nuclear 
membranes,  there  is  cotranslational  addition  of two  high 
mannose-type oligosaccharides (41,  49).  After synthesis,  G 
protein is rapidly transferred to a site in the Golgi complex, 
where its oligosaccharides are modified and become resistant 
to removal by the enzyme endo H (23). Thus the time course 
of transport of G  protein to this site can be measured from 
its rate of acquisition of endo H-resistant oligosaccharides. To 
determine the  time course of transport of G  proteins with 
short cytoplasmic domains, cells transfected with pGu, pG*, 
and pa 1473H 1 were pulse-labeled with [35S]methionine,  then 
chased by incubation in  medium containing unlabeled me- 
thionine for various lengths of  time. Immunoprecipitates from 
cells at each time point were treated with endo H, and labeled 
proteins were analyzed by SDS-polyacrylamide gel  electro- 
phoresis and fluorography (Fig.  3). The time course of trans- 
port of G  protein containing a  Ur, cytoplasmic domain was 
slower (h/2  =  105  min) than that observed for the wild type 
Figure 2.  Double-label indirect immunofluorescence microscopy showing surface and internal staining of wild type and mutant G  proteins. 
COS-1  cells grown on coverslips were transfected with plasmids encoding the indicated proteins. Approximately 40-44 h after transfection, 
cells were fixed and cell-surface G proteins were labeled with rabbit anti-VSV and rhodamine- or Texas Red-conjugated anti-rabbit IgG. After 
permeabilization with detergent, the internal G  protein was stained with mouse anti-VSV and fluorescein-conjugated anti-mouse IgG. The 
same field is shown in each pair of fluorescence micrographs. Typical internal (left panels) and surface (fight panels) labeling patterns for each 
of the indicated proteins is shown. Bar, -10 um. 
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proteins.  5-cm dishes of COS-1 cells were transfected with  10 ug of 
pSVGL (encoding the wild type G protein), pG/~, laG*, or pa1473Hl. 
At 40 h posttransfection,  cells were pulse-labeled for  15  min with 
[35S]methionine, then chased by incubation  in medium containing 
unlabeled  methionine  for the indicated  times (in minutes).  Immu- 
noprecipitates  of cells from each time point were incubated  in the 
presence  (+)  or  absence  (-)  of endo  H  and  analyzed  by  SDS- 
polyacrylamide gel electrophoresis. Fluorograms of the dried gels are 
shown  (A  and  B).  The  mobility  of G  proteins  after  removal  of 
oligosaccharides by endo H is indicated for the wild type (arrow) and 
mutant (arrowheads)  G proteins. As expected, the apparent molecular 
weights of G  proteins  with  shortened  cytoplasmic  domains deter- 
mined on SDS-polyacrylamide gels were less than that observed for 
the wild type G protein.  Preexposed x-ray films obtained  from this 
and similar experiments were quantified by densitometry and the rate 
of acquisition  of endo H-resistant  oligosaccharides for each of the 
glycoproteins was calculated. Results presented are the means of at 
least two experiments (C). 
G  protein (t,/2 =  20 min). G  protein containing only the first 
three  normal amino acids in its cytoplasmic domain  had a 
similarly  reduced  rate  of acquisition  of endo  H-resistant 
oligosaccharides. We also found that in some cases, 4 or 6 h 
after synthesis, as much as  15-25%  of 1473H1  glycoprotein 
molecules had acquired resistance to cleavage by endo H. 
Rates of ~m and G Protein Transport in a B  Cell Line 
To determine if the rate of transport of G  protein with a ~m 
cytoplasmic domain was similar to the normal rate of trans- 
port oflgM to the cell surface, we analyzed the #m glycoprotein 
produced  in  the  B  lymphoma  cell  line  WEHI  231.  IgM 
produced by these cells has been well characterized by others 
(42) and the nucleotide sequences of the genes encoding its 
membrane (~m) and secreted (•)  forms have been determined 
(44).  WEHI 231  cells have characteristics of an  undifferen- 
tiated  B  lymphocyte that  produces  #m  and  us  mRNAs  in 
similar amounts,  both  of which are  translated  into protein 
(34). They synthesize large quantities of monomeric lgM as a 
membrane receptor, but they do not secrete IgM due to lack 
of synthesis  of the  J  polypeptide  chain  and  possibly  other 
components required  to assemble  the  pentameric  form  for 
secretion (28).  It has been determined that biosynthesis and 
maturation of tzm occurs via a pathway similar to the VSV G 
protein from the rough ER through the Golgi complex to the 
plasma membrane (36,  53, 60), however an accurate rate of 
transport  for  this  protein  is  difficult  to  extrapolate  from 
existing  data  (17,  60).  Thus,  we  performed  an  experiment 
similar to that performed on COS-transfected cells to measure 
the  rate of acquisition  of endo H-resistant  oligosaccharides 
by immunoglobulin ~,~ molecules. 
WEHI 231  cells were  pulse-labeled with  [35S]methionine, 
then chased by incubation in medium containing unlabeled 
methionine for various lengths of time. Detergent extracts of 
cells harvested at each time point were subjected to immu- 
noprecipitation  with  anti-tz  or  anti-~  sera.  To  identify  the 
mature form of IgM on the cell surface, WEHI 231  cells were 
subjected to  radioiodination  followed by immunoprecipita- 
tion with antisera directed against ~ heavy chains, lmmuno- 
precipitated proteins were reduced, alkylated, and precipitated 
with acetone before incubation with endo H  and analysis by 
SDS-polyacrylamide  gel  electrophoresis  and  fluorography 
(Fig.  4).  The  half-time  for acquisition  of endo  H-resistant 
oligosaccharides by Gu in COS-1 cells was ~2 h and similarly 
the half-time for acquisition of such oligosaccharides by 35S- 
labeled #m was 2  h  in WEHI 231  cells.  The electrophoretic 
mobility of the ['25I]-labeled cell surface form of Ur, increases 
after incubation with endo H  (Fig. 4, lanes 16 and  17) as  1- 
2 oligosaccharides on the mature protein are unprocessed and 
of the  high  mannose-type,  thus  susceptible  to  removal  by 
endo H  (25). Virtually all the 35S-labeled Um was mature 8 h 
after synthesis (Fig. 4, lanes 14 and 15) and comigrated with 
the ~2~I-labeled ~m, consistent with the fact that (given a half- 
time of 2 h) ~94%  of the Ur, molecules have passed through 
the  Golgi  complex.  Although  turnover  of both  m  and  /d  m 
occurred during this experiment, analysis by densitometry of 
radioactivity in each form of u,, at the time points shown in 
Fig. 4  as well as earlier time points (e.g.,  30 min) indicated 
that no selective degradation of the endo H-sensitive form of 
#m  occurred in these  cells (data  not shown;  17). Thus,  the 
ratio of Um molecules in the endo H-resistant  form to total 
um  molecules  can  be  used  to  determine  a  time  course  of 
transport  of IgM  from  the  rough  ER  through  the  Golgi 
complex in WEHI 231 cells. 
Parallel  immunoprecipitations  of detergent  extracts  with 
antibodies directed against either u or K chains demonstrated 
that excess free heavy or light chains were detectable imme- 
diately after synthesis (Fig. 4, lanes 4 and 6) and not at later 
times (Fig. 4, lanes 2, 3, 8, and  12) indicating that the time 
course of transport of ~m cannot be attributed to a deficiency 
in  synthesis  of light  chains  by  cells  at  this  stage  of B  cell 
differentiation. In fact, the association between the two chains 
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cells were pulse-labeled  for 10 min with [35S]methionine, then chased 
by incubation in medium containing unlabeled methionine for the 
indicated times (in hours). IgM molecules on the cell surface  were 
labeled with [x2~I] using lactoperoxidase. Detergent extracts from 1.2 
X  10  6  labeled cells  were  subjected to  immunoprecipitation with 
antisera directed against ~ heavy chains (lanes 6-17), or normal goat 
serum  (lane  5,  control).  Also, extracts  from  6  x  102  cells were 
subjected to immunoprecipitation with antiserum directed against 
light chains (lanes 2-4). Immunoprecipitates were reduced and alky- 
lated before incubation in the presence (+) or absence (-) ofendo H. 
Proteins were  analyzed by SDS-polyacrylamide gel electrophoresis 
and a fluorograph of the dried gel is shown.  The apparent molecular 
weight  of ~,m  and  ~,  synthesized  by these  cells is indicated. The 
electrophoretic  mobility  of  urn and #s after removal of  oligosaccharides 
by endo H is shown by large and small arrowheads, respectively. No 
IgM is secreted from these cells and #s is degraded intracellularly  (39; 
our  unpublished results).  Molecular weight  markers are the  VSV 
proteins: L (240,000), G (65,000), N (50,000), and M (27,000). 
appeared complete as early as 30  min  after synthesis, since 
the ratio of Um:K at this and all later times of chase (Fig. 4, 
lanes 8-15) closely resembled the steady-state ratio of the two 
polypeptides (data not shown). These results indicated that in 
our pulse-chase experiments, we were examining assembled 
IgM  molecules  rather  than  a  pool  of free  ~mS  blocked  in 
transport in rough ER due to a deficiency of association with 
K light chains. Similar rates of intracellular transport of urnS 
have been suggested for IgM molecules synthesized in murine 
spleen cell populations (60). 
To determine whether WEHI 231  cells have a  generalized 
defect in ability to transport glycoproteins, we also measured 
the  time course  of transport of G  protein in  VSV-infected 
WEHI 231  cells. WEHI 231  cells were infected with VSV for 
5  h  and pulse-chase experiments were performed. Detergent 
extracts  of  cells  from  each  time  point  were  subjected  to 
immunoprecipitation with  antiserum  directed against VSV 
and immunoprecipitated proteins were treated with endo H 
as described for transfected COS-1  cells. Proteins were ana- 
lyzed by SDS-polyacrylamide  gel electrophoresis and fluorog- 
raphy  (Fig.  5).  The  half-time  of acquisition  of endo  H- 
resistant oligosaccharides in the Golgi complex by G  protein 
was 20  min, similar to G  protein in other infected cell types 
and in cells that express the cloned G  gene (Fig. 6A; 26, 48). 
It was interesting to  note that  similar to human  pre-B cell 
lines (12), infection of WEHI 231  cells or another murine B 
lymphoma line A20.2J (64) did not result in efficient shut-off 
of host  cell protein  synthesis.  Yet,  infection  with  VSV  of 
X16c8.5  cells, another murine  B  lymphoma line which ex- 
presses IgM and  IgD on  the cell surface (30),  did result in 
efficient shut-off of synthesis of endogenous  proteins (data 
not shown).  Nonetheless, the time course of transport of G 
protein in  all B  cell lines tested was  virtually identical and 
indicated that normal transport mechanisms were functional 
in these cells. 
Transport of G protein with the Cytoplasmic Domain 
of an Influenza  Virus Hemagglutinin Protein 
Since G  protein with a  #m cytoplasmic domain appeared to 
be transported to  the  cell surface with  kinetics that  closely 
resembled  transport  of IgM  to  the  surface  of B  cells,  we 
constructed a G  gene which encoded the cytoplasmic domain 
of another viral glycoprotein transported to the cell surface as 
rapidly as G  protein. We chose the carboxyl-terminal domain 
Figure 5. Time course of transport of G protein in VSV-infected B 
cells. WEHI 231 cells were infected with 30 plaque-forming units of 
VSV/cell for 5 h. Infected cells were pulse-labeled with [35S]methio- 
nine for 5 min, then chased by incubation in medium containing 
unlabeled methionine for the indicated times (in minutes).  Detergent 
extracts were analyzed directly (lane 0' NO IP) or after immunopre- 
cipitation with anti-VSV serum.  Immunoprecipitates of cells from 
each time point were incubated in the presence (+) or absence (-) of 
endo H and analyzed by SDS-polyacrylamide  gel electrophoresis.  A 
tluorograph of the dried gel is shown. The arrow indicates the appar- 
ent molecular weight of G protein after removal of oligosaccharides 
by endo H. 
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glycoprotein cytoplasmic domains: 5-cm dishes of COS-I  cells were 
transfected  with plasmid  DNA encoding the indicated  proteins.  At 
40 h posttransfection  cells were pulse-labeled for 15 min with  [35S] 
methionine,  then chased by incubation in medium containing unla- 
beled methionine  for the indicated times (in minutes). Immunopre- 
cipitates of cells from each time point were incubated in the presence 
(+) or absence (-) of endo H and analyzed by SDS-polyacrylamide 
gel electrophoresis. Fluorograms  of the dried gels are shown (A-C). 
The mobility of  G proteins after removal of oligosaccharides by endo 
H is indicated for the wild type (arrow) and mutant (arrowheads) G 
proteins.  The  apparent  molecular  weights  of mutant  G  proteins 
determined  on  SDS-polyacrylamide  gels was  consistent  with  the 
substitution  of a 10 amino acid cytoplasmic domain (GHA)or a 130 
amino acid cytoplasmic domain (G23) for the normal 29 amino acid 
cytoplasmic domain of wild type G protein.  Preexposed x-ray films 
obtained  from this and similar experiments were quantified  by den- 
sitometry and the rate of  acquisition of endo H-resistant oligosaccha- 
rides by each glycoprotein was calculated. Results presented are the 
means of at least two experiments (D). 
of the HA glycoprotein of influenza virus which contains  10 
amino acid residues presumably exposed on the cytoplasmic 
side of the membrane.  Nucleotides encoding the cytoplasmic 
domain of an influenza virus HA (strain A/Aichi/2/68; 61) 
were  substituted  for  the  first  30  nucleotides  encoding the 
cytoplasmic domain of  G protein (pGHA) as described in Fig. 
1 and in Materials and Methods. When double-label indirect 
immunofluorescence microscopy was performed  on COS-1 
cells transfected with pGHA, the patterns of cell surface and 
internal staining were similar to those observed for the wild 
type G  protein in transfected cells (data not shown). We also 
performed  pulse-chase  experiments  to  determine  the  time 
course of transport  through the Golgi complex  of GHA in 
transfected COS-1  cells.  Immunoprecipitates from detergent 
extracts of  cells harvested at each time point were treated with 
endo H, and labeled proteins were analyzed by SDS-polyac- 
rylamide gel electrophoresis and  fluorography (Fig.  6).  The 
half-time of acquisition of endo H-resistant oligosaccharides 
by GHA (tl/2 --  60  min)  was slower than  for wild type G 
protein but was not as slow as for G# or G*.  We measured 
the time course of transport of HA in influenza virus-infected 
COS-1  cells  and  the  half-time  of acquisition  of endo  H- 
resistant  oligosaccharides by  an  HA  encoded  by influenza 
virus  strain  A/Aichi/2/68  was  -20-30  min,  as  has  been 
reported  by  others  for  HA  encoded  by  another  strain  of 
influenza virus (19). 
Transport of G Protein with the Cytoplasmic Domain 
of a Coronavirus p23 Protein 
We also examined the ability of  the cytoplasmic domain from 
a  viral glycoprotein that is not normally destined  for incor- 
poration  into  the  plasma  membrane  to  substitute  for  the 
cytoplasmic domain of  G protein. Coronaviruses such as IBV 
bud from intracellular membranes and their small glycopro- 
teins,  designated  p23  for IBV,  appear  only in  intracellular 
membranes in virus-infected cells (16, 40). The sequences of 
cDNAs  encoding p23  predict  a  polypeptide  of 225  amino 
acids which has a short extracytoplasmic domain containing 
two sites  for addition  of N-linked oligosaccharides followed 
by three hydrophobic domains which are believed to span the 
membrane  three  times.  The  carboxyl-terminal  123  amino 
acids are  relatively hydrophilic and probably constitute  the 
cytoplasmic domain of the protein (9; Rose, J., unpublished 
results). 
Although our attempts to express the full-length p23 protein 
from cloned  cDNA have  been  unsuccessful,  we  wanted  to 
determine if its cytoplasmic domain could prevent transport 
of G  protein to the cell surface. A cDNA-encoding G  protein 
containing the putative cytoplasmic domain of the IBV p23 
glycoprotein (pG23) was constructed as described in Materials 
and Methods. The cDNA constructed encoded a hybrid pro- 
tein  consisting of the  extracellular  and  transmembrane  do- 
mains of G  protein and a cytoplasmic domain consisting of 
three amil~o acid residues  derived  from G  protein  fused to 
the carboxyl-terrninal 128 amino acids of p23 which included 
its  putative  cytoplasmic domain.  Double-label  indirect  im- 
munofluorescence microscopy of  COS-1 cells transfected with 
pG23  showed both cell surface and internal  staining similar 
to that  observed for wild type G  protein  (data  not shown). 
We also measured the rate of acquisition of endo H-resistant 
oligosaccharides by G23  (Fig.  6)  and  the  half-time  was  25 
min, almost as fast as G  protein with its normal cytoplasmic 
domain. 
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The transport of membrane and secretory proteins to the cell 
surface  is  thought to  occur along the  same basic  pathway 
from the ER, through the three to four compartments of the 
Golgi complex to the cell surface (51). In principle,  one can 
imagine that sorting of proteins within this pathway occurs in 
two  ways.  In  the  "positive  signal"  model,  recognition  of 
sorting signals by specific factors would result in direct move- 
ment of proteins to specific locations within the cell. In the 
"negative signal"  model,  all proteins would move (perhaps 
with phospholipids or cholesterol destined for various cellular 
membranes) unless  they were  delayed at specific  sites  after 
recognition by specific  factors.  It is  well documented that 
different  proteins  move  through  the  exocytic  pathway  at 
different rates  (22, 56), and this observation could be recon- 
ciled  with  either model for sorting.  That  is,  proteins could 
have different affinities for the same transport factors resulting 
in  different rates  of transport,  or they could have different 
affinities  for  resident  components along the  pathway,  and 
thus move through the cell at different rates. 
Given the complexity of the transport process which pre- 
sumably requires that some proteins segregate into transport 
vesicles while others do not, it seems likely that both positive 
and negative  signals operate within the exocytic pathway. In 
a transmembrane protein, the sorting signals could reside  in 
the  cytoplasmic domain,  the  transmembrane  domain,  the 
extracytoplasmic domain or in  some combination of these 
domains. In fact, mutations in any of these domains of VSV 
G  protein  can  arrest  transit  from  the  rough  ER  or Golgi 
complex, whereas  other changes in these domains have little 
or no effect on transport of  G protein to the plasma membrane 
(2, 33, 47). In an initial  search for sorting signals in the VSV 
G  protein,  two considerations led  us to analyze mutations 
affecting  the cytoplasmic domain (47).  First,  this domain is 
separated from the remainder of the protein by an a-helical 
segment of 20 amino acid residues that spans the membrane, 
and thus it seemed unlikely that changes in the cytoplasmic 
domain would affect the folding of the extracytoplasmic do- 
main of the protein on the other side of the membrane. The 
second  consideration  was  that  the  cytoplasmic domain  is 
localized where it might be expected to interact with proteins 
or other factors involved in formation of transport vesicles or 
in subsequent fusion of these vesicles with various membrane 
compartments in  the cell. The results  of the earlier  studies 
indicated  that  the  structure  of the  cytoplasmic domain  is 
important in signaling a normal rate of  transport of  G protein 
to the cell surface (47).  We undertook the experiments de- 
scribed  here to extend these earlier studies and to ask specifi- 
cally if cytoplasmic domains from other integral  membrane 
proteins could substitute for the normal cytoplasmic domain 
of VSV G protein in transport to the plasma membrane. 
In the earlier experiments it was found that substitution of 
two to  three  uncharged amino acids  for the  normal  cyto- 
plasmic domain of G protein (mutant 1473H 1) resulted  in a 
G  protein  that  accumulated  in  the  rough  ER  and  Golgi 
membranes, but not on the cell surface (47). In fact, we show 
here (using a more sensitive reagent) that the 1473H1 protein 
was detected on the plasma membrane of ~20% of the cells 
expressing  this protein. Also, we detected a small percentage 
of conversion of  the oligosaccharides  on the protein to a form 
resistant  to cleavage by endo H, indicating some transfer of 
1473H 1 from the rough ER through the Golgi complex. From 
these  experiments  we  conclude that  the  two  to  three  un- 
charged amino acids in the cytoplasmic domain of 1473H1 
were  sufficient  for expression  of G  protein  on  the  plasma 
membrane. Thus,  none of the  normal cytoplasmic domain 
was essential  for transport of G  protein to the cell surface. 
However,  the  rate  of transport  of this  protein  lacking  the 
entire  normal cytoplasmic domain was at least 30-fold lower 
than the rate  of transport of the wild  type G  protein.  This 
slow rate  of transport of 1473H1  could account for the fact 
that only a small proportion of  COS-1 cells expressing  1473H 1 
had detectable  levels of this protein on the cell surface  at 40 
h after transfection.  That is, in the transient expression system 
used here, most of the cells may not have had sufficient time 
to transport and accumulate detectable  levels of the mutant 
protein on the cell surface after initiation of protein synthesis. 
The results obtained with a new mutant G* demonstrated 
that the presence of  only the three membrane-proximal amino 
acids  (Arg-Val-Gly)  from  the  normal  cytoplasmic domain 
resulted in significantly greater expression  of G protein on the 
cell surface than observed with mutant 1473H 1. However the 
rate of  acquisition ofendo H-resistant oligosaccharides  by G* 
was sixfold slower than for the wild type G protein. A second 
mutant (G#) with the three amino acid cytoplasmic domain 
from the  immunoglobulin u  membrane heavy chain  (Lys- 
Val-Lys)  showed a  rate  of acquisition  of endo H-resistant 
oligosaccharides  and level of expression  on the plasma mem- 
brane virtually identical  to that of G*.  The presence  of the 
one  basic  amino  acid  residue  in  these  short  cytoplasmic 
domains  could  be  responsible  for  promoting  the  fivefold 
increase in the rate of transport of the mutant proteins to the 
cell surface  (as compared with  1473H1).  In a  recent report, 
rates of processing were determined for H-2L  d with mutations 
in  the  cytoplasmic domain and,  similar  to our results,  the 
presence of  basic amino acid residues greatly enhanced expres- 
sion of mutant  H-2L  d on the cell  surface  (66).  Also,  these 
results are consistent with observations of Lehrman et al. in 
which a mutation in the low density lipoprotein receptor that 
leaves  tFree  of the  50  normal  amino  acid  residues  in  the 
cytoplasmic domain generates  a mutant protein that is trans- 
ported to the plasma membrane but at a rate slower than the 
wild type protein (31). 
It was interesting  that the time course of transport of G# in 
COS-1  cells was virtually identical  to the time course mea- 
sured for #m in WEHI 231 cells. The time course we observed 
also  resembled  the  rate  of acquisition  of endo  H-resistant 
oligosaccharides  by #m in the human B lymphoblastoid cell 
line  Daudi in  which the pulse-labeled  Um and m forms are 
more difficult  to resolve on SDS-polyacrylamide gels (17). A 
similar transit time has been suggested  for 6m molecules in 
B 1-8& 1 cells (3). The Um molecules synthesized in these two 
cell lines and 6m molecules differ in their extracellular  domains 
with respect to amino acid composition and extent of glyco- 
sylation yet their transmembrane and cytoplasmic domains 
are identical  (6). Thus,  very different  glycoproteins,  Urn, ~,,, 
and  G~,, which  contain  an  identical  cytoplasmic  domain 
consisting  of the three amino acids Lys-Val-Lys,  are  trans- 
ported to the cell surface  at very similar rates.  These results 
would be consistent with a model ofintracellular glycoprotein 
transport in which important interactions occur on the cyto- 
plasmic side of intracellular  membranes. In the case of these 
three proteins we would suggest that the amino acid sequence 
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although perhaps weak, transport signal.  In the case of wild 
type  G  protein,  the  complete  cytoplasmic domain  might 
provide for stronger interactions and result in its more rapid 
rate of transport. 
In  this  study  we  demonstrated  that  G  protein  with  an 
influenza virus HA cytoplasmic domain was transported three 
times more slowly than either the wild type G or HA protein 
in COS-1  cells.  A  reasonable interpretation  of this result is 
that the structure of the cytoplasmic domain  of HA is less 
important than that of G protein in signaling efficient transfer 
to the cell surface. That mutations in the cytoplasmic domain 
of HA  have  a  much  less  profound  effect  on  the  rate  of 
acquisition of endo H-resistant oligosaccharides by mutant 
HA  molecules (15)  than  do  mutations  in  the  cytoplasmic 
domain  of the  VSV  G  protein  (47)  is consistent with  this 
hypothesis. Thus, the HA protein may rely more heavily than 
G  protein on extracytoplasmic signals to promote its rapid 
transport to the cell surface. Because the HA protein is known 
to be a trimer (63) while G protein may be a monomer (14), 
an alternative explanation is that the extracellular and trans- 
membrane domains of G  protein are not structurally com- 
patible with the HA cytoplasmic domain. For example, per- 
haps the cytoplasmic domain of HA is efficiently recognized 
in a trimeric configuration, and since such a conformation is 
unexpected in  the hybrid protein, the  rate of transport ob- 
served for GHA was reduced as compared with either parent 
molecule. 
Addition  of 127  amino  acids which  constitute the  cyto- 
plasmic domain of 1BV p23 to G* greatly increased the hybrid 
protein's rate of intracellular transport. This observation was 
interesting in view of the fact that coronaviruses encode two 
transmembrane glycoproteins, one that is transported to the 
surface of infected cells, and the other that remains localized 
in rough ER and Golgi membranes (l 6, 40). The location of 
p23  in  these  intracellular  membranes is  believed to  direct 
budding of coronaviruses from infected cells.  We conclude 
from our experiment that  the  cytoplasmic domain  of p23 
cannot halt G protein in intracellular membranes. Instead, it 
increases the rate of transport of G  protein with three of its 
normal amino acids in the cytoplasmic domain, at least from 
the rough ER through the Golgi complex. Other domains of 
p23 may provide signals that halt transfer of p23 beyond the 
Golgi  complex.  Further  experiments on  expression  of p23 
itself and  other G-p23  hybrid proteins are  in  progress and 
may allow identification of features of the p23 protein that 
are critical for targeting to intracellular membranes. 
The results described here demonstrate that precise replace- 
ment  of cytoplasmic domains,  as can  be achieved by site- 
directed mutagenesis, can result in production of hybrid pro- 
teins whose functional domains can be directly assayed in the 
absence of endogenous or extraneous amino acids. This is in 
contrast to expression of chimeric cDNAs generated by re- 
combination  at  restriction  sites  which  can  result  in  novel 
properties which resemble neither parent glycoprotein (37). 
The experiments also illustrate the  complexity involved in 
analysis of the sorting problem using recombinant DNA and 
gene expression technology. Although the simple methods we 
describe allow the precise replacement of small protein do- 
mains with the corresponding domains from other proteins, 
the results obtained with these proteins are not always con- 
sistent with simple models. However, considering that pro- 
teins  potentially contain  signals in  more than  one domain 
that function actively to promote transport, as well as signals 
that may retard transport at certain stages,  it is possible to 
arrive  at  consistent  models  to  explain  the  results  without 
invoking effects of the  cytoplasmic domain  on  the  three- 
dimensional structure of the extracytoplasmic domain of the 
protein  as  suggested  by  Doyle  et  al.  (15).  Having precise 
constructs encoding hybrid glycoproteins correctly targeted to 
the plasma membrane of transfected cells, we can now begin 
to assess directly the biological roles of the cytoplasmic do- 
main of G  protein in targeting to specific plasma membrane 
domains in  epithelial cells,  in  assembly of VSV virions, in 
lateral diffusion of G protein, and in immune recognition. 
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